Passion for Innovation. Compassion for Patients.™ Daiichi Sankyo Europe GmbH

Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo Europe GmbH

Lung Cancer Awareness Month

Furthering the Conversation around Biomarker Testing

In October, we recognized Breast Cancer Awareness Month (BCAM) by putting a spotlight on the importance of biomarker testing as it can be used by doctors to better understand the type of cancer a person has and can inform treatment decisions.[1] We spoke with patients to better understand their perspectives on biomarker testing and uncover how they learnt about it.

As we enter Lung Cancer Awareness Month (LCAM) this November, we are exploring what patients did with the information once they learnt about biomarker testing, and what it meant for their journeys. Through conversations with  patients, we have uncovered a few key insights about biomarker testing.

  1. Speak with your Healthcare Team
    Receiving a cancer diagnosis can be overwhelming, and it’s difficult to know the right questions to ask your healthcare team. Information about biomarker testing can be found on advocacy group websites, in your healthcare team’s office, or even in unlikely places such as from a family friend. We are working with Lung Cancer Europe (LuCE) to support their “Get checked” campaign.
     
  2. Understand the Results
    Once you’ve received a biomarker test, the conversation doesn’t end there. It’s important to walk through the results with your healthcare team to ensure you understand the findings and your cancer type.
     
  3. Decide on a Treatment Plan
    After reviewing the results, your healthcare team will work with you to develop an individualized treatment plan based on your specific type of cancer. This may include a targeted therapy, which is a type of treatment that targets a specific biomarker.[2]
     

Our Commitment to Patients
We are dedicated to raising understanding of the importance of biomarker testing beyond these awareness months so that people diagnosed with cancer have more information to help inform decision making with your healthcare team.

Follow us on LinkedIn and Twitter throughout the month as we continue to share resources to help others in recognition of LCAM.

References

[1] Cancer Biomarker Testing | American Cancer Society Cancer Action Network (fightcancer.org) [accessed 10.11.2021]

[2] National Cancer Institute. Targeted Therapy to Treat Cancer. Available at: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed: October 2021.